Search
You have searched for "biomedical"
Showing 1-10 of 593
Brazil airlifts emergency oxygen into pandemic-struck state, vaccine drive lags
MANAUS/BRASILIA (Reuters) - Brazil's Air Force flew emergency oxygen supplies on Friday to the jungle state of Amazonas devastated by a resurgent pandemic and the government scrambled to organize nationwide vaccinations while President Jair Bolsonaro said he "should be at the beach."
Sinovac vaccine 78% effective in Brazil trial, experts call for more details
SAO PAULO (Reuters) - A coronavirus vaccine developed by China's Sinovac Biotech was 78% effective in a late-stage Brazilian trial with no severe COVID-19 cases, researchers said on Thursday, although a lack of data details stirred calls for more transparency.
Brazil to import two million AstraZeneca vaccine doses, not yet approved for use
BRASILIA (Reuters) - Brazil's health regulator Anvisa said late on Saturday it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.
Exciting innovations in the works
Despite funding constraints and challenges brought on by the pandemic, research remains a priority for the country’s top higher education institutions.
Brazil eyes emergency use for AstraZeneca vaccine after UK approval
SAO PAULO/BRASILIA (Reuters) -Brazil will soon weigh emergency-use approval for AstraZeneca's COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America's largest country rushes to catch up with immunization programs under way around the hard-hit region.
Brazil to seek regulatory approval for AstraZeneca vaccine on January 15
RIO DE JANEIRO (Reuters) - Brazil's Fiocruz biomedical institute will seek approval for the Oxford University/AstraZeneca vaccine against COVID-19 with federal health regulator Anvisa on Jan. 15, one of the center's senior officials said on Monday.
Roundup: Phase 3 trial of Novavax investigational COVID-19 vaccine starts
WASHINGTON, Dec. 28 (Xinhua) -- The Phase 3 trial of another investigational COVID-19 vaccine has begun enrolling adult volunteers, the U.S. National Institutes of Health (NIH) announced on Monday.
Phase 3 trial of Novavax investigational COVID-19 vaccine starts
WASHINGTON, Dec. 28 (Xinhua) -- The Phase 3 trial of another investigational COVID-19 vaccine has begun enrolling adult volunteers, the U.S. National Institutes of Health (NIH) announced on Monday.
In Brazil, vaccine trial volunteers hope to save lives, not win fame
SAO PAULO (Reuters) - From doctors weary of seeing patients die to relatives who lost their loved ones, thousands of Brazilians have volunteered for COVID vaccine trials in one of the world's worst-affected countries in the hope their quiet heroism will save lives.
